Shoes for self-managing Chronic HIP Pain: the SCHIPP randomised clinical trial
- Conditions
- Chronic hip painMusculoskeletal - Other muscular and skeletal disorders
- Registration Number
- ACTRN12621001532897
- Lead Sponsor
- niversity of Melbourne
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 120
a.aged greater than or equal to 45 years;
b.activity-related hip joint pain; and
c.either no morning hip joint stiffness or stiffness that lasts no longer than 30 minutes;
ii)report history of hip pain of at least 3 months duration;
iii)report hip pain on most days of the past month;
iv)report a minimum hip pain score of 4 out of 10 on an 11-point NRS (terminal descriptors of ‘no pain’ and ‘worst pain possible’) during walking over the previous week.
i)diagnosed in the past 12 months by a health professional as having gluteal tendinopathy, greater trochanteric pain syndrome, referred hip pain from the lumbar spine or femoro-acetabular impingement syndrome;
ii)recent hip surgery (past 6 months) or planned surgery in next 6 months;
iii)current use of shoe orthoses, customized shoes or brace (on any joint of lower limb);
iv)current regular use of high heels, thongs or work boots that would restrict ability to wear allocated trial shoes 6 hours/day;
v)had any hip injection in the past 3 months or planning an injection in next 6 months;
vi)self-report other muscular or joint condition anywhere in the body which is worse than study hip pain;
vii)self-report any systemic or inflammatory joint disease (e.g. fibromyalgia, rheumatoid arthritis, gout);
viii)any neurological condition affecting the spine or either lower limb;
ix)current or planned use of a gait aid in the next 6 months;
x)inability to understand written/spoken English; and
xi)unable to commit to study requirements (eg wearing shoes, attending appointments, completing outcomes, do not have foot size in the range of 8 to 13US for men, and 7 to 12US for women).
xii) hip replacement on the most painful side
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of hip pain during walking<br>Scored on an 11-point numerical rating scale (NRS) for average overall hip pain on walking in the last week. <br>Ranges from 0 to 10; where 0=no pain and 10=worst pain possible.[ Baseline and 6 months after randomisation]
- Secondary Outcome Measures
Name Time Method